Skip to main content
Abattis Bioceuticals Corp. logo

Abattis Bioceuticals Corp. — Investor Relations & Filings

Ticker · ATTBF ISIN · CA00258G1037 LEI · 5493000GEXZZJ997G829 CSE Professional, scientific and technical activities
Open in API
Filings indexed 442 across all filing types
Latest filing 2020-06-18 Regulatory Filings
Country CA Canada
Listing CSE ATTBF

About Abattis Bioceuticals Corp.

https://www.abattis.com

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company. Its core business involves aggregating, integrating, and investing in cannabis technologies and related biotechnology services. The company is engaged in the development and licensing of natural health products and health solutions, often focusing on applications for chronic illnesses in human and animal health sectors, particularly within the framework of the legal cannabis industry.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a corporate and operational update from Abattis Bioceuticals Corp. It includes information about trading halt status, operational performance, product launches, financial filing status, management changes, and COVID-19 response. It references the filing of annual audited financial statements and management discussion and analysis for the fiscal year ended September 30, 2019, but does not contain the actual financial statements or detailed financial data itself. The document is more of a comprehensive update and status report rather than a formal financial report like an Annual Report (10-K) or Interim Report (IR). It also does not fit into categories like earnings release or capital update. Given the nature of the content, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements and corporate updates that do not fit other specific categories.
2020-06-18 English
News release - English.pdf
Regulatory Filings
2020-05-30 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2020-04-30 English
Annual MD&A - English.pdf
Regulatory Filings
2020-04-30 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2020-04-30 English
News release - English.pdf
Regulatory Filings
2019-11-08 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.